RWPA
AVNS

Richard W. Paul & Associates’s Avanos Medical AVNS Stock Holding History

Richard W. Paul & Associates’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5
Closed -$100 – 502
2024
Q1 		$100 Hold
5
– – ﹤0.01% 500
2023
Q4 		$112 Hold
5
– – ﹤0.01% 488
2023
Q3 		$101 Hold
5
– – ﹤0.01% 496
2023
Q2 		$128 Hold
5
– – ﹤0.01% 526
2023
Q1 		$149 Hold
5
– – ﹤0.01% 536
2022
Q4 		$135 Buy
+5
New +$122 ﹤0.01% 527

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Richard W. Paul & Associates's AVNS Position: Q2 2024 in Review

Richard W. Paul & Associates sold out of Avanos Medical (AVNS) in Q2 2024, closing a stake of 5 shares — an estimated $100 sold.

Richard W. Paul & Associates first reported a position in AVNS in Q4 2022 and held it in 6 quarters. The position peaked at $149 in Q1 2023. 258 funds tracked by Wall St. Rank hold AVNS as of Q2 2024.

  • Richard W. Paul & Associates reported no remaining Avanos Medical position as of Q2 2024 after selling out during the quarter.
  • Richard W. Paul & Associates sold 5 Avanos Medical shares in Q2 2024, an estimated $100.
  • Richard W. Paul & Associates first reported a position in Avanos Medical in Q4 2022 and held it in 6 quarters.
  • Richard W. Paul & Associates's Avanos Medical position peaked at $149 in Q1 2023.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2024.

Based on Richard W. Paul & Associates's 13F filing for Q2 2024, filed 23 Jul 2024.